Good MorningThe rally on Wall Street hit another roadblock on Thursday despite better-than-expected economic data. The data included ISM services and factory orders which both came in better than expected. The news sent the S&P 500 up in early trading but resistance capped the gains at the key 4,150 level. If the market can not get above this level soon another round of selling could follow and there is a catalyst due out on Friday.
The NFP report is expected to show a slowdown in hiring that is also foreshadowed by the jobless claims data. The number of initial and total claims for unemployment continues to rise and suggests a topping in the labor markets. Topping in the labor market is good news for inflation but bad news for the economy because it will undercut consumer spending growth and weigh on the outlook for economic activity and corporate earnings. Featured: These 4 Stocks... (Buy The Dip) (WIA) 
|
Markets | | | Global stock markets and Wall Street futures are mixed ahead of an update on the health of the U.S. jobs market while the Federal Reserve weighs whether more rate hikes are needed to cool surging inflation Read the Full Story >> |
|
|
Stocks | | |
Although not back to pre-pandemic levels, occupancy rates at many hotel chains are recovering. That’s the conclusion of Smith Travel Accommodations Research (STR). In the same survey, the research firm concluded that RevPAR (revenue per available room) and ADR (average daily rate) are also o... Read the Full Story >> |
|
Markets | | |
Membership warehouse club operator BJ’s Wholesale Club Holdings (NYSE: BJ) stock is one of the rare stocks actually trading up 3% for 2022. Rising inflation and fuels prices have driven the consumers to warehouse clubs away from traditional retailers as households tighten their budgets. BJ&r... Read the Full Story >> |
|
From Our PartnersA former advisor to the CIA and Pentagon now believes President Biden plans to retire the US dollar we know.
And replace it with what he calls 'Biden Bucks'. It is underway. | | See what Biden signed in Executive Order 14067 |
|
Markets | | |
It hasn’t been an incredibly fun year for investors in Cedar Fair (NYSE: FUN) stock. The company’s share price is down 19.5% for the year. And that loss is even worse for investors who entered a position when the stock was at its 52-week high in mid-February.
But after the amus... Read the Full Story >> |
|
Markets | | |
FuelCell Energy (NASDAQ: FCEL) along with other stocks in the industrial sector was sold off recently following the news that the US senate would not sponsor a package that would introduce new spending to tackle climate change. Since then, the stock is currently up 2.34%, so some investors have wo... Read the Full Story >> |
|
From Our PartnersVirginia Stock-Picking Millionaire Says It's Not About Diversification! One single stock under $5 - that trades under a secret name- could help you build your retirement | | His details are here.
|
|
Politics | | | India’s central bank on Friday raised its key interest rate by 50 basis points to 5.4% in its third such hike since May as it focuses on containing inflation.
Reserve Bank of India Governor Shaktikanta Das projected inflation at 6.7% in this financial year. June was the sixth consecut... Read the Full Story >> |
|
Tech | | | Elon Musk accused Twitter of fraud in a countersuit over his aborted $44 billion deal for the social media company, which he said held back necessary information and misled his team about its true user base Read the Full Story >> |
|
Politics | | | Reining in the soaring prices of insulin has thus far been elusive in Congress, although Democrats say they'll try again — as part of their economic package that focuses on health and climate.
The price of the 100-year-old drug has more than tripled in the last two decades, forcing th... Read the Full Story >> |
|
Politics | | | Economies in the Asia-Pacific are forecast to hit the doldrums this year as decades-high inflation and the war in Ukraine compound geopolitical uncertainties and the aftereffects of the pandemic.
A report on Pacific Rim economies by the Asia Pacific Economic Cooperation forum said Fr... Read the Full Story >> |
|
Stocks | | |
MarketBeat reported that Freeport McMoran Inc (NYSE: FCX) submitted its earnings card this week. The results were mixed, with the company's net income contracting $840M from $1083M last year. The company's EPS also shrank from 0.57 to 73 cents from the same quarter last year. On a positive note, c... Read the Full Story >> |
|
The Early Bird Stock Of The DayFriday: Stock With Insider Buying Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas. | | View Today's Stock Pick |
|
